An open-label, randomized clinical trial on teicoplanin infection prophylaxis in pediatric patients with acute myeloid leukemia
Latest Information Update: 05 Aug 2024
At a glance
- Drugs Teicoplanin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- Acronyms Pro-Teico
- 09 Aug 2021 Planned number of patients changed from 130 to 131.
- 23 Apr 2021 Planned number of patients changed from 131 to 130.
- 24 Nov 2020 Planned End Date changed to 27 Apr 2024.